Sign in

CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857 702 0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
  1. 8-K Event Results of operations
  2. 8-K Event Executive or director change
  3. 8-K Event Other events
  4. 8-K Event Results of operations
  5. 8-K Event Executive or director change · Shareholder vote results
  6. 8-K Event Results of operations
  7. 8-K Event Executive or director change
  8. DEF 14A Proxy Proxy Statement
  9. 8-K Event Executive or director change · Regulation FD disclosure
  10. 8-K Event Executive or director change
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. 8-K Event Other events
  14. 8-K Event Results of operations
  15. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure · Other events
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Shareholder vote results
  18. 8-K Event Regulation FD disclosure
  19. 10-K Report Annual Report
  20. 8-K Event Material agreement · Unregistered share sale

Page 1 of 2 · 24 filings